About the journal
Acta Materia Medica is an open-access journal published by Compuscript Ltd in Ireland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Compuscript Ltd
- ISSN
- 2737-7946
- Country
- Ireland
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 162
- Declared review time
- 13 weeks
- Declared peer-review model
- peer_review
- Official website
- https://amm-journal.org/
Index listings
- DOAJ · 2023-09-22
- PUBMED · 2022-07-21
- Indexing
- DOAJ · PUBMED
- APC
- —
- Declared review time (DOAJ)
- 13 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
162
Most recent article
last month
Average review time (journal-declared via DOAJ)
13weeks
Works in OpenAlex
161
Last recorded publication year
2026
h-index
21
i10-index
51
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2023-09-22
- Added to DOAJ
- 2023-09-22
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 7%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9918350485506676
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- Computational Drug Discovery Methods
- Histone Deacetylase Inhibitors Research
Show all subjects (50)
- Pharmacological Effects of Natural Compounds
- Computational Drug Discovery Methods
- Histone Deacetylase Inhibitors Research
- Pharmacological Effects of Natural Compounds
- Advanced Nanomaterials in Catalysis
- Peptidase Inhibition and Analysis
- Ferroptosis and cancer prognosis
- Advanced Drug Delivery Systems
- Ferroptosis and cancer prognosis
- Advanced Nanomaterials in Catalysis
- Peptidase Inhibition and Analysis
- Advanced Drug Delivery Systems
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Multiple Myeloma Research and Treatments
- Berberine and alkaloids research
- Drug Transport and Resistance Mechanisms
- Multiple Myeloma Research and Treatments
- Drug Transport and Resistance Mechanisms
- Cancer, Hypoxia, and Metabolism
- Berberine and alkaloids research
- Nanoparticle-Based Drug Delivery
- MicroRNA in disease regulation
- Nanoparticle-Based Drug Delivery
- Liver Disease Diagnosis and Treatment
- MicroRNA in disease regulation
- Liver Disease Diagnosis and Treatment
- Cancer-related molecular mechanisms research
- Diabetes Treatment and Management
- Microbial Natural Products and Biosynthesis
- Advancements in Transdermal Drug Delivery
- Rheumatoid Arthritis Research and Therapies
- Diabetes Treatment and Management
- Microbial Natural Products and Biosynthesis
- Rheumatoid Arthritis Research and Therapies
- Advancements in Transdermal Drug Delivery
- Cancer-related molecular mechanisms research
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
Keywords (DOAJ)
- pharmacology
- toxicology
- medicinal chemistry
- clinical pharmacy
- pharmacoepidemiology
- pharmacoeconomics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ